Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PLD1 | Q13393 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.40 |
| ▸ | PDCD1 | Q15116 | 3/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 3/20 | 0.40 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.40 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.40 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | PAK4 | O96013 | 1/20 | 0.40 |
| ▸ | ABL1 | P00519 | 1/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9645383 | 0.79 | KDM4E (0.33) | CRBNALOX5ALDH1A1KDM4EHPGD | |
| SCHEMBL9645835 | 0.75 | ALDH1A1 (0.44) | CRBNSMN1; SMN2GAAMAPK1ALDH1A1 | |
| SCHEMBL15785562 | 0.74 | PLD1 (0.49) | CRBNALOX5SMN1; SMN2PLD1GAA | |
| SCHEMBL9645705 | 0.73 | ALOX5 (0.46) | CRBNALOX5SMN1; SMN2PLD1GAA | |
| SCHEMBL1977844 | 0.72 | CD274 (0.45) | CRBNALOX5SMN1; SMN2PLD1GAA | |
| SCHEMBL9644560 | 0.69 | CYP1A2 (0.52) | SMN1; SMN2MAPK1ALDH1A1CYP1A2POLB | |
| SCHEMBL7964509 | 0.68 | CRBN (0.47) | CRBNALOX5SMN1; SMN2PLD1GAA | |
| SCHEMBL19062530 | 0.68 | ALOX5 (0.64) | CRBNALOX5SMN1; SMN2PLD1GAA | |
| SCHEMBL5449252 | 0.68 | CD274 (0.47) | CRBNALOX5SMN1; SMN2PLD1GAA | |
| SCHEMBL2198674 | 0.67 | CRBN (0.63) | CRBNALOX5SMN1; SMN2PLD1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020156285-A1 | Novel herbicides | KUNZ WALTER (CH) | 2002-10-24 | — | — | US | disclosed |
| US-6380134-B1 | USED FOR CONTROLLING WEEDS | SYNGENTA CROP PROTECTION, INC. | 2002-04-30 | — | — | US | disclosed |
| US-6369002-B1 | HETERO IS PYRIMIDINE OR PYRIDAZINE; 1-(3-FLUORO-5-CHLORO PYRIDIN-2-YL)-3-METHYL-4-TRIFLUOROMETHYLPYRIMIDIN-2,6-DIONE | SYNGENTA CROP PROPERTIES, INC. | 2002-04-09 | — | — | US | disclosed |
| CN-1301262-A | Novel herbicide | NOVARTIS AG (CH) | 2001-06-27 | — | — | CN | disclosed |
| CN-1295570-A | N-pyriconyl herbicides | NOVARTIS AG (CH) | 2001-05-16 | — | — | CN | disclosed |
| EP-1084117-A2 | NOVEL HERBICIDES | Novartis AG (CH) | 2001-03-21 | — | — | EP | disclosed |
| EP-1076655-A1 | N-PYRIDONYL HERBICIDES | Novartis AG (CH) | 2001-02-21 | — | — | EP | disclosed |
| EP-1076656-A2 | N-HETEROARYL-SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES | Novartis AG (CH) | 2001-02-21 | — | — | EP | disclosed |
| WO-1999055693-A2 | N-HETEROARYL-SUBSTITUTED PYRIDINE DERIVATIVES AND THEIR USE AS HERBICIDES | NOVARTIS AG (CH) | 1999-11-04 | — | — | WO | disclosed |
| WO-1999052893-A1 | N-PYRIDONYL HERBICIDES | NOVARTIS AG (CH) | 1999-10-21 | — | — | WO | disclosed |
| WO-1999052892-A2 | NOVEL HERBICIDES | NOVARTIS AG (CH) | 1999-10-21 | — | — | WO | disclosed |
| US-5086052-A | Antiarthritic, antiallergens, antiinflammatory agents; also for asthma and psoriasis | ABBOTT LABORATORIES (US) | 1992-02-04 | — | — | US | disclosed |
| US-4970210-A | ENZYME INHIBITORS | ABBOTT LABORATORIES (US) | 1990-11-13 | — | — | US | disclosed |
| EP-0299449-A2 | Pyridazinone, triazinone and oxapyridazinone lipoxygenase inhibiting compounds | ABBOTT LABORATORIES (US) | 1989-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020156285-A1 | Novel herbicides | DDT, CBR1, CBR3 | CRBN 2647/4885ALOX5 4636/4885SMN1; SMN2 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.